Pfizer Facing Profit Drop After Record Year as COVID Vaccine Demand Fades
Three analysts have downgraded the drug giant's stock ahead of Tuesday's quarterly results and annual guidance.
Three analysts have downgraded the drug giant's stock ahead of Tuesday's quarterly results and annual guidance.
:max_bytes(150000):strip_icc()/the-ultimate-guide-to-amex-membership-rewards-5070975-1500-final-1-1-1db266d318b24b2b9428a3ff4e1d5947.png){kind=small}
:max_bytes(150000):strip_icc()/January23MortageRatesNews-10-86673d429db746529be6f88be7ea8758.jpg){kind=small}
:max_bytes(150000):strip_icc()/boeing-aircraft-southwest-airlines-AIRNEWS0721-90d44a8c058146a58bfc44c8cfad708d.jpg){kind=small}
